Layoffs
October 2023 Layoff Tracker: Biotech & Pharma Sector Shifts
In the ebb and flow of the Biotech and Pharma sectors, workforce adjustments reflect not only individual corporate strategies but ...
Kronos Bio Slashes Staff by 19% to Fund Upcoming Solid Tumor Trial
Kronos Bio is undergoing a strategic reorganization, including a staff reduction of 19%, following promising early trial results for a ...
Rani Therapeutics and Sangamo Cut Staff and Operations to Secure 2024 Viability
Rani Therapeutics and Sangamo Therapeutics are the latest biotech companies to implement substantial workforce reductions as part of their strategies ...
ResMed to cut 5% of workforce amid fiscal challenges
As ResMed seizes opportunities in the CPAP machine market, left open due to Philips’ ongoing respiratory device recall issues, the ...
Pfizer Announces New Jersey Site Closure and Layoffs in $3.5B Cost-Cutting Initiative
The financial ramifications of Pfizer’s revenue decline due to the COVID-19 pandemic are now revealing their human toll as the ...
ElevateBio slashes 13% of workforce despite huge fundraising
Despite having a substantial $401 million in funding, ElevateBio is streamlining its operations, resulting in job cuts that will impact ...
Amgen to cut 350 jobs after acquiring Horizon for $28 billion
Recently, in the aftermath of Amgen’s substantial $27.8 billion acquisition of Horizon, unveiled in December and finalized this month, these ...
Idorsia slashes 300 jobs in R&D amid cost-cutting efforts
The company has announced that it will be reducing its workforce by 300 individuals, with a focus on R&D and ...
BrainStorm cuts 30% staff, eyes ALS cell therapy approval
BrainStorm Cell Therapeutics has chosen an unconventional route in response to its recent setback in securing approval. While the decision ...
Biogen cuts jobs at Reata after $2.95 billion deal for kidney drug rights
A mere fortnight after the completion of Biogen’s acquisition of Reata Pharmaceuticals, the newly merged entity is taking a scalpel ...
Sana slashes staff and drops in vivo CAR-T program to cut costs
Sana Biotechnology, amid challenging stock performance, is undergoing its second significant restructuring in less than a year. This move involves ...
Fujifilm Irvine Scientific and Formulated Solutions announce over 50 layoffs each, according to filings
In the midst of a recent wave of workforce reductions within the biopharma sector, two contract manufacturers have implemented significant ...
Eikon announces layoffs as part of its restructuring plan to improve efficiency and profitability
Eikon Therapeutics, a biotechnology company that attracted top executives from Merck & Co. and secured substantial financing, has implemented staff ...
uniQure cuts staff and R&D projects to extend gene therapy cash runway
uniQure, a biotech company focused on gene therapy, is implementing a significant workforce reduction as part of a strategic restructuring ...
Kezar Faces Significant Staff Loss, CEO Persists in Advancing Lead Lupus Candidate to Phase 2 Milestone
Kezar Life Sciences is embarking on a significant restructuring plan aimed at preserving cash resources over the next two years ...
Syros slashes workforce and appoints new CEO amid partnership losses
Syros Pharmaceuticals is undergoing a significant transformation, which includes a workforce reduction of 35%, as it narrows its focus to ...
PTC cuts jobs as Europe withdraws approval for its DMD drug
PTC Therapeutics has announced an expansion of its previously planned workforce reductions as European regulatory concerns cast a shadow over ...
Galecto slashes workforce, explores options after failed fibrosis trial
Boston-based biotech firm Galecto is facing a significant workforce reduction of 70%, affecting 29 employees, following the discontinuation of its ...
ImmunityBio cuts 50 jobs in California and Florida after FDA snubs its bladder cancer drug
Following an FDA rejection earlier this year, ImmunityBio has initiated its second round of layoffs in less than a year, ...
Bayer’s new CEO plans to slash management jobs as part of a major restructuring: Reuters
Bill Anderson, Bayer’s relatively new CEO, is reportedly gearing up to make substantial changes within the pharmaceutical giant, starting with ...
2seventy Bio slashes 176 jobs and looks for new CEO after cell therapy setback
2seventy bio, the spinoff from bluebird bio, is undergoing significant changes under the leadership of CEO Nick Leschly. The company ...
Novartis Announces New Round of Layoffs at US Headquarters Following Earlier Job Cuts
Novartis, a Swiss pharmaceutical giant, is set to undergo another round of job cuts at its U.S. headquarters in East ...
ICU Medical to layoff 82 workers, wind down operations at Minnesota facility
In a strategic move, ICU Medical has revealed plans to permanently shut down a manufacturing facility in Minnesota, a decision ...
Biogen anticipates 1,000 further layoffs by 2025 as it navigates a “transition”
Source – Biogen During the announcement of its first-quarter earnings, Biogen revealed its strategic decision to discontinue the development of ...
